| Atara Biotherap (ATRA) | |||
|---|---|---|---|
| 3.63 0.19 (5.52%) | 08-08 16:00 | ||
| Open: | 3.58 | Pre. Close: | 3.44 |
| High: | 3.73 | Low: | 3.52 |
| Volume: | 1,725,297 | Market Cap: | 339M |
| Prices Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 3.732 - 3.743 | 3.743 - 3.756 |
| Low: | 3.488 - 3.501 | 3.501 - 3.515 |
| Close: | 3.607 - 3.627 | 3.627 - 3.649 |
| Stock Technical Analysis | |
|---|---|
| Overall: |  |
| Target: | Six months: 8.00 One year: 10.91 |
| Support: | Support1: 2.83 Support2: 2.35 |
| Resistance: | Resistance1: 6.85 Resistance2: 9.34 |
| Pivot: | 3.29  |
| Moving Averages: | MA(5): 3.32  MA(20): 3.68 MA(100): 6.33 MA(250): 11.70 |
| MACD: | MACD(12,26): -0.74 Signal(12,26,9): -0.83 |
| %K %D: | %K(14,3): 56.42 %D(3): 41.36 |
| RSI: | RSI(14): 41.20 |
| 52-Week: | High: 20.04 Low: 2.83 Change(%): -70.7 |
| Average Vol(K): | 3-Month: 2059 10-Days: 2218 |
| Price, MAs and Bollinger Bands |
|---|
| Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ ATRA ] has closed below upper band by 17.1%. Bollinger Bands are 65.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend. |
| Stock chart |
|---|
 |
| Financial Analysis | |
|---|---|
| Price to Book Value: | Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. | |
| Price to Earnings: | Outperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). | |
| Discounted cash flow: | Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. | |
| Return on Assets: | Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. | |
| Return on Equity: | Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. | |
| Debt to Equity: | Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. | |
| Stock Basics & Statistics | |
|---|---|
| Exchange: NASDAQ Global Select | |
| Sector: Healthcare | |
| Industry: Biotechnology | |
| Shares Out. (M) | |
| Shares Float (M) | 93.41 |
| % Held by Insiders | 70270000.00 |
| % Held by Institutions | 0.72 |
| Shares Short (K) | 11270 |
| Shares Short Prior Month (K) | |
| Stock Financials | |
|---|---|
| EPS | -341649984.000 |
| Book Value (p.s.) | |
| Profit Margin | |
| Operating Margin | |
| Return on Assets (ttm) | 454.0 |
| Return on Equity (ttm) | -47.3 |
| Qtrly Rev. Growth | 24100000.0 |
| Gross Profit (p.s.) | 98.056 |
| Sales Per Share | -103.954 |
| EBITDA (p.s.) | 18833332.000 |
| Qtrly Earnings Growth | -3.64 |
| Operating Cash Flow (M) | |
| Levered Free Cash Flow (M) | -239.35 |
| Stock Valuation | |
|---|---|
| PE Ratio | |
| PEG Ratio | |
| Price to Book value | |
| Price to Sales | -0.04 |
| Price to Cash Flow | 1.63 |
| Stock Dividends | |
|---|---|
| Dividend | |
| Dividend Yield | |
| Dividend Growth | 8040000.000 |
